PPARD and hepatocellular carcinoma: The activation of PPARβ/δ has been proposed to inhibit liver tumorigenesis in hepatitis B transgenic mice [100]; however, in different human hepatocellular carcinoma cell lines, the activation of PPARβ/δ enhanced the growth of these cancer cells through the activation of cyclooxygenase (COX)-2 [101].